Exagen Inc. Profile Avatar - Palmy Investing

Exagen Inc.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosi…

Medical - Diagnostics & Research
US, Vista [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Exagen Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of XGN's Analysis
CIK: 1274737 CUSIP: 30068X103 ISIN: US30068X1037 LEI: - UEI: -
Secondary Listings
XGN has no secondary listings inside our databases.